Mark Massaro
Stock Analyst at BTIG
(3.60)
# 809
Out of 4,944 analysts
135
Total ratings
51.72%
Success rate
21.75%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Maintains: Buy | $65 → $60 | $44.00 | +36.36% | 17 | Aug 12, 2025 | |
| MXCT MaxCyte | Downgrades: Neutral | n/a | $1.42 | - | 4 | Aug 11, 2025 | |
| TEM Tempus AI | Initiates: Buy | $60 | $69.35 | -13.48% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $12.79 | -29.63% | 5 | Dec 18, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.29 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $12.25 | -42.86% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $4.76 | +47.06% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $152.36 | +47.68% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $156.05 | -13.49% | 13 | Aug 9, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $116.88 | -61.50% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $56.56 | -11.60% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $658.00 | -11.85% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $6.21 | +238.16% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.88 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.80 | +185.71% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.99 | +167.56% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $19.31 | +55.36% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $9.50 | -47.37% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $12.62 | +98.10% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.36 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $0.99 | +253.04% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $100.51 | +198.48% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $68.41 | -26.91% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $179.04 | -37.44% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $270.13 | -38.92% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $26.40 | +203.03% | 9 | Sep 10, 2018 |
Exact Sciences
Aug 12, 2025
Maintains: Buy
Price Target: $65 → $60
Current: $44.00
Upside: +36.36%
MaxCyte
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.42
Upside: -
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $69.35
Upside: -13.48%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $12.79
Upside: -29.63%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.29
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $12.25
Upside: -42.86%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $4.76
Upside: +47.06%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $152.36
Upside: +47.68%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $156.05
Upside: -13.49%
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $116.88
Upside: -61.50%
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $56.56
Upside: -11.60%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $658.00
Upside: -11.85%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $6.21
Upside: +238.16%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.88
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.80
Upside: +185.71%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.99
Upside: +167.56%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $19.31
Upside: +55.36%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $9.50
Upside: -47.37%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $12.62
Upside: +98.10%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.36
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.99
Upside: +253.04%
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $100.51
Upside: +198.48%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $68.41
Upside: -26.91%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $179.04
Upside: -37.44%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $270.13
Upside: -38.92%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $26.40
Upside: +203.03%